soul trial oral semaglutide Presented at #ACC25: Among participants with type 2 diabetes and cardiovascular disease, chronic kidney disease, or both, (14 mg) was associated with a lower risk of cardiovascular events than placebo SOUL: Oral Semaglutide Bests Usual
Description
The Unmet Challenge of Medication Nonadherence
Neighborhood Medical Center
Does Zepbound cause dizziness
MacCloud supervises your protocol at ARTC.
How should employers and other health plan sponsors think about covering or reducing the cost of covering expensive GLP-1s
